Shenzhen New Industries Biomedical (300832.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · China · ISIN CNE100003T39
Shenzhen New Industries Biomedical financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.54 bn CNY | 4.58 bn CNY |
| Gross profit | 3.27 bn CNY | 3.17 bn CNY |
| Operating income | 2.11 bn CNY | 1.81 bn CNY |
| EBIT | 1.93 bn CNY | 1.86 bn CNY |
| Net income | 1.83 bn CNY | 1.62 bn CNY |
| Diluted EPS – continuing operations | 2.33 CNY | 2.06 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shenzhen New Industries Biomedical
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
More stocks
- CHEMED CORP (CHE)
- President Chain Store Corp (2912.TW)
- Jardine Cycle & Carriage Ltd (C07.SI)
- Alexandria Real Estate Equities (ARE)
- Valaris Ltd (VAL)
- MonotaRO Co Ltd (3064.T)
- Union Electric Company (UEPEO)
- Primo Brands Corp (PRMB)
- Koninklijke Vopak NV (VPK.AS)
- MSA Safety Inc (MSA)
- Yealink Network Technology Corp Ltd (300628.SZ)
- Nkt A/S (NKT.CO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.